181 related articles for article (PubMed ID: 21816136)
1. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome.
Yilmaz G; Köksal I; Karahan SC; Mentese A
Clin Biochem; 2011 Oct; 44(14-15):1227-30. PubMed ID: 21816136
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome.
Hoenigl M; Raggam RB; Wagner J; Valentin T; Leitner E; Seeber K; Zollner-Schwetz I; Krammer W; Prüller F; Grisold AJ; Krause R
Clin Biochem; 2013 Feb; 46(3):225-9. PubMed ID: 23159293
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) compared to C-reactive protein (CRP) and procalcitonin (PCT) in children with systemic inflammatory response syndrome (SIRS).
Şirinoğlu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Yalındağ-Öztürk N; Cinel İ; Yaman A; Haklar G; Şirikci Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
J Infect Chemother; 2017 Jan; 23(1):17-22. PubMed ID: 27771157
[TBL] [Abstract][Full Text] [Related]
4. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
[TBL] [Abstract][Full Text] [Related]
6. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
[TBL] [Abstract][Full Text] [Related]
7. [Ventilator bundle treatment of acute respiratory distress syndrome and its correlation with biomarkers of inflammation].
Yang J; Dong C; Li J; Zhang H; Zhang H; Song R; Yang Z; Feng F; Qi Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Aug; 26(8):544-8. PubMed ID: 25124901
[TBL] [Abstract][Full Text] [Related]
8. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
[TBL] [Abstract][Full Text] [Related]
9. Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.
Uusitalo-Seppälä R; Huttunen R; Tarkka M; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
J Intern Med; 2012 Sep; 272(3):247-56. PubMed ID: 22755554
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis.
Zhao JJ; Lou XL; Chen HW; Zhu FT; Hou YQ
Cell Mol Biol Lett; 2018; 23():22. PubMed ID: 29760745
[TBL] [Abstract][Full Text] [Related]
11. suPAR as a prognostic biomarker in sepsis.
Donadello K; Scolletta S; Covajes C; Vincent JL
BMC Med; 2012 Jan; 10():2. PubMed ID: 22221662
[TBL] [Abstract][Full Text] [Related]
12. [Kinetics, diagnostic and prognostic value of procalcitonin after cardiac surgery].
Kallel S; Abid M; Jarraya A; Abdenadher M; Mnif E; Frikha I; Ayadi F; Karoui A
Ann Biol Clin (Paris); 2012 Oct; 70(5):567-80. PubMed ID: 23047903
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit.
Loonen AJ; de Jager CP; Tosserams J; Kusters R; Hilbink M; Wever PC; van den Brule AJ
PLoS One; 2014; 9(1):e87315. PubMed ID: 24475269
[TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase plasminogen activator receptor: an indicator of pneumonia severity in children.
Wrotek A; Jackowska T; Pawlik K
Adv Exp Med Biol; 2015; 835():1-7. PubMed ID: 25315615
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of procalcitonin for bacterial infection in elderly patients in the emergency department.
Lai CC; Chen SY; Wang CY; Wang JY; Su CP; Liao CH; Tan CK; Huang YT; Lin HI; Hsueh PR
J Am Geriatr Soc; 2010 Mar; 58(3):518-22. PubMed ID: 20163483
[TBL] [Abstract][Full Text] [Related]
16. [Significance of serum procalcitonin levels in the evaluation of severity and prognosis of patients with systemic inflammatory response syndrome].
Huang WP; Jiang WQ; Hu B; Ye H; Zeng HK
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 May; 24(5):294-7. PubMed ID: 22587926
[TBL] [Abstract][Full Text] [Related]
17. Soluble receptor for urokinase plasminogen activator in community-acquired pneumonia in children.
Wrotek A; Pawlik K; Jackowska T
Adv Exp Med Biol; 2013; 788():329-34. PubMed ID: 23835994
[TBL] [Abstract][Full Text] [Related]
18. [Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac operation].
Dong Z; Jianxin Z; Haraguchi G; Arai H; Mitaka C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):478-9. PubMed ID: 25163104
[TBL] [Abstract][Full Text] [Related]
19. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.
Savva A; Raftogiannis M; Baziaka F; Routsi C; Antonopoulou A; Koutoukas P; Tsaganos T; Kotanidou A; Apostolidou E; Giamarellos-Bourboulis EJ; Dimopoulos G
J Infect; 2011 Nov; 63(5):344-50. PubMed ID: 21839112
[TBL] [Abstract][Full Text] [Related]
20. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
Kofoed K; Andersen O; Kronborg G; Tvede M; Petersen J; Eugen-Olsen J; Larsen K
Crit Care; 2007; 11(2):R38. PubMed ID: 17362525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
